“…Included studies were from the United States (n=7) [ 20 , 37 , 39 , 41 , 44 , 50 , 52 ], United Kingdom (n=5) [ 38 , 43 , 47 , 48 , 51 ], Canada (n=2) [ 42 , 49 ], New Zealand (n=1) [ 40 ], France (n=1) [ 46 ], and Australia (n=1) [ 45 ]. Study methodology included in-depth or semistructured face-to-face interviews [ 38 , 40 , 42 , 43 , 48 , 49 ], surveys and questionnaires [ 20 , 44 - 48 , 50 - 52 ], focus groups [ 37 , 49 ], and analysis of online blog posts and comments [ 39 , 41 ]. Experiences with technologies examined included studies on CGM [ 38 , 39 , 44 , 49 - 52 ], FGM [ 46 ], CPGM [ 20 ], insulin pump therapy and bolus advisers [ 43 ], CSII [ 45 ], SAPT [ 42 ], and HCL/CL [ 37 , 48 ].…”